Prof. Jamie Vandenberg - Statement about SyncroPatch Technology

icon sp96   “In my lab we use the SyncroPatch 384PE, as it allows us to reliably screen KCNH2 mutations, the gene encoding hERG K+ channels, in high-throughput. This is a very fast process and it enables us to screen large mutation libraries. Recently, we have validated a high-throughput functional phenotyping assay capable of distinguishing benign KCNH2 variants from those that have a dominant negative effect, using the SyncroPatch 384PE. We are very happy with this result and plan to expand assay development to other ion channel genes.”

Prof. Dr. Jamie Vandenberg, co-deputy director and head of cardiac electrophysiology 
The Victor Chang Cardiac Research Institute, Australia

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.